Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The growing complexity of platelet aggregation.

Shaun P Jackson1

  • 1Australian Centre for Blood Diseases, Monash University, Melbourne, Australia. shaun.jackson@med.monash.edu.au

Blood
|February 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering ultrapotent trivalent anticoagulants through hybridisation of salivary peptides from multiple haematophagous organisms.

Chemical science·2025
Same author

SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.

The Journal of clinical investigation·2025
Same author

Ischaemic endothelial necroptosis induces haemolysis and COVID-19 angiopathy.

Nature·2025
Same author

Development of supramolecular anticoagulants with on-demand reversibility.

Nature biotechnology·2024
Same author

Integrating Phenotypic and Chemoproteomic Approaches to Identify Covalent Targets of Dietary Electrophiles in Platelets.

ACS central science·2024
Same author

GPIbα-filamin A interaction regulates megakaryocyte localization and budding during platelet biogenesis.

Blood·2023

Platelet aggregation is a complex, multistep process influenced by blood flow conditions. New research reveals distinct, shear-dependent mechanisms that could lead to safer antiplatelet therapies.

Area of Science:

  • Hematology
  • Vascular Biology
  • Biophysics

Background:

  • Platelet aggregation is vital for hemostasis and thrombosis, traditionally viewed as a simple fibrinogen-mediated process.
  • The integrin alpha(IIb)beta(3) receptor and fibrinogen were considered the primary components of platelet aggregation.
  • Recent advancements allow real-time in vivo analysis, revealing greater complexity than previously understood.

Purpose of the Study:

  • To investigate the complex and dynamic nature of platelet aggregation.
  • To identify distinct mechanisms initiating platelet aggregation under varying conditions.
  • To explore the potential for developing targeted antiplatelet therapies.

Main Methods:

  • Real-time in vivo analysis of platelet aggregation.

Related Experiment Videos

  • Investigation of receptor-ligand interactions under different blood flow conditions.
  • Characterization of shear-dependent mechanisms of platelet activation.
  • Main Results:

    • Platelet aggregation is a multistep adhesion process involving multiple receptors and ligands.
    • At least three distinct mechanisms initiate platelet aggregation.
    • Each mechanism operates within specific blood shear rate ranges in vivo.

    Conclusions:

    • Platelet aggregation is significantly more complex than previously thought, involving shear-dependent mechanisms.
    • Understanding these distinct mechanisms opens avenues for developing targeted, vascular-bed-specific antiplatelet agents.
    • Future therapies could offer improved safety and efficacy over current antiplatelet drugs.